Evidence map›Paper›PMID 28851350›Full record

ArticleBMC complementary and alternative medicine2017

Preventive effects of the novel antimicrobial peptide Nal-P-113 in a rat Periodontitis model by limiting the growth of Porphyromonas gingivalis and modulating IL-1β and TNF-α production.

Hong-Yan Wang, Li Lin, Wei Fu, Hui-Yuan Yu, Ning Yu, Li-Si Tan, Jya-Wei Cheng, Ya-Ping Pan

Open access · goldAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 36 citations in OpenAlex.

  1. Impact of LiveMicroorganisms · 2025
    Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Emerging strategies for combatingExploration (Beijing, China) · 2024
    Review
  7. Review
  8. Article
  9. Journal of oral microbiology · 2024
    Article
  10. Review
  11. Review
  12. Review
  13. Archives of Razi Institute · 2022
    Review
  14. Role of Hydrogen Sulfide in Oral Disease.Oxidative medicine and cellular longevity · 2022
    Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Hong-Yan WangDepartment of Periodontics and Oral Biology, School of Stomatology, China Medical University, Shenyang, 110002, China.
Li LinDepartment of Periodontics and Oral Biology, School of Stomatology, China Medical University, Shenyang, 110002, China.
Wei FuDepartment of Pharmacy, Tongji Hospital Affiliated with Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Hui-Yuan YuInstitute of Biotechnology and Department of Medical Science, National Tsing Hua University, Hsinchu, 300, Taiwan.
Ning YuDepartment of Periodontics and Oral Medicine, University of Michigan, School of Dentistry, Ann Arbor, MI, USA.
Li-Si TanDepartment of Periodontics and Oral Biology, School of Stomatology, China Medical University, Shenyang, 110002, China.
Jya-Wei ChengInstitute of Biotechnology and Department of Medical Science, National Tsing Hua University, Hsinchu, 300, Taiwan.
Ya-Ping PanDepartment of Periodontics and Oral Biology, School of Stomatology, China Medical University, Shenyang, 110002, China. yppan_perio@163.com.
China Medical University · CNNational Tsing Hua University · TWTongji Hospital · CNUniversity of Michigan–Ann Arbor · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundP-113 (AKRHHGYKRKFH-NH2) is a 12-amino-acid histidine-rich peptide derived from histatin 5 that is highly degradable in high salt concentrations and biological fluids such as serum, plasma and saliva. Nal-P-113, a novel antimicrobial peptide whose histidine residues are replaced by the bulky amino acids β-naphthylalanine, causes the antimicrobial peptide to retain its bactericidal activity even in physiological environments. This study evaluated the effect of the novel antimicrobial peptide Nal-P-113 in a rat periodontitis model and the mechanisms of action of Nal-P-113 for suppressing periodontitis.

methodsPeriodontitis was induced in mandibular first molars in rats receiving a ligature and infected with Porphyromonas gingivalis. Animals were randomly divided into six groups: a, P. gingivalis W83 alone; b, P. gingivalis W83 with 6.25 μg/mL of Nal-P-113; c, P. gingivalis W83 with 25 μg/mL of Nal-P-113; d, P. gingivalis W83 with 100 μg/mL of Nal-P-113; e, P. gingivalis W83 with 400 μg/mL of Nal-P-113; and f, control without P. gingivalis W83 or Nal-P-113. Morphometric analysis was used to evaluate alveolar bone loss. Microbiological assessment of the presence of Porphyromonas gingivalis and total bacteria was performed using absolute quantitative real-time PCR and scanning electron microscopy. Gingival tissue was collected for western blot and immunohistochemical assays of IL-1β and TNF-α levels.

resultsAlveolar bone loss was inhibited by 100 μg/mL or 400 μg/mL of Nal-P-113 compared to the control group (P < 0.05). Lower amounts of P. gingivalis and total bacteria were found in groups d and e compared with group a (P < 0.05). A decrease in the levels of IL-1β and TNF-α was detected in group d and group e compared to the control group (P < 0.05). The amount of P. gingivalis was positively correlated with IL-1β and TNF-α expression in periodontal tissue (P < 0.05).

conclusionsNal-P-113 exhibited protective effects on Porphyromonas gingivalis-induced periodontitis in rats by limiting the amount of bacteria and modulating IL-1β and TNF-α production. The use of Nal-P-113 in vivo might serve as a beneficial preventive or therapeutic approach for periodontitis.

Indexed as

AnimalsDisease Models, AnimalHumansInterleukin-1betaMalePeptidesPeriodontitisPorphyromonas gingivalisRatsRats, Sprague-DawleyTumor Necrosis Factor-alphaInterleukin-1betaPeptidesTumor Necrosis Factor-alphaAlveolar bone lossAnimal modelAntimicrobial peptideInflammatory responsePeriodontitisPorphyromonas gingivalis

Identifiers

PMID28851350
PMCPMC5576277
OpenAlexW2753332713

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.